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In human tissues two main N-acetyln6-D-hexos- 
aminidases, A and B, have been found [1, 2]. A 
previous investigation [3] has shown that tire normal 
pattern of these enzymes is altered in tissues of 
patients afflicted with Try-Sachs disease. Three dif- 
ferent types of enzyme pattern have been observed, 
corresponding to three variants of Tay-Sachs disease. 
All three variants are characterized by a strong ac- 
cumulation of TSG (GalNAc*~-I, 4-[NeuNAc-2,3]- 
Gal-l,4-Glc-l,l-[2-N-acyl] sphingosine) and a minor 
one of trihexosylceramide (GalNAc-/3-1,4-Gal-1,4-Glc- 
1,1-[2-N-acyl] sphingosine). In two of these variants 
a defect of N-acetyl-~-D-hexosaminidase A-activity 
was stated [4 6]. Up to now the enzymatic degrad- 
ation of TSG had been established only with extracts 
from calf brain [7] and from human muscle [8], the 
latter, containing both N-acetyl@D-hexosaminidases 
A and B. In this paper it will be shown that the 
human N-acetyl-/~-D-hexosaminidase A is responsible 
for the in vitro degradation of TSG. This was done 
with a purified enzyme preparation. 
Fig. 1 shows the scheme for the purification of 
N-acetylhexosaminidases A and B from postmortem 
human liver. The A and B enzyme forms were en- 
riched 3000-fold and l O00-fold respectively; the 
details of the purification procedure will be presented 
elsewhere. One mg of the purified enzyme A could 
hydrolyze 138.5//moles of p-nitrophenyl-N-acetyl- 
* A bhreviations: 
Gal : D-galactose; 
GalNAc : N-acetyi-D-galactosamine; 
Glc : D-glucose; 
NeuNAc: N-acetylneuraminic a id. 
13-D-glucosaminide and 1.4/lmoles of trihexosylcer- 
amide per minute. One mg of the purified enzyme 
B splits 5 1.7/*moles and 0.65/~mole per min of the 
same respective substrates. Both enzymes are also ca- 
pable of acting upon kidney globoside (GalNAc-/3-t ,3- 
Gal-1,4-Gal- 1,4-Glc-1,1 [2-N-acyl] sphingosine). This 
lipid is additionally accumulated in the visceral organs 
of the variant of Tay-Sachs disease with both enzyme 
forms A and B missing [9]. 
The substrate, TSG, was radioactively labelled by 
hydrogenation of the sphingosine moiety with tritium 
gas and purified by column chromatography with 
silicic acid and florisil 1101. The specific activity of 
the labelled substrate was determined by dilution 
with non-radioactive TSG according to Snyder and 
Stephens [11] in a liquid scintillation counter and 
found to be 5500 cpm/nmole. 
This radioactive TSG was then used to study the 
action of the purified enzyme preparation. 2 units** 
of N-acetyl-/J-D-hexosaminidase A were incubated 
24 hr at 37 ° with 40/.tg TSG, 2.5 mg of a crude 
sodium taurocholate (Schuchardt, Munich), 50 #1 1 
M citrate buffer in a final volume of 0.5 ml at pH 
4.7. Subsequently, 40 #1 aliquots of the incubation 
mixtures were analysed by thin-layer chromatography. 
The thin-layer plates were prepared from a suspension 
of 60 g Kieselgel G (Merck, Darmstadt) in 128 ml 
0.06 M disodium tetraborate solution, air-dried and 
activated before use by treatment at 120 ° for 3 hr. 
** One unit of N-acetyl-t3-D-hexosaminidase hydrolyzes 1
~tmole p-nitrophenyl-N-acetyl-/3-D-glucosaminide in 0.1 M
citrate buffer, pH 4.4 containing 0.01% albumin, in 1 
min at 37 °. 
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Fig. 1. Scheme for the purification ofN-acetyl-#-D-hexosaminidases A nd B from postmortem human liver. 
The solvent system for the separation of  the reaction 
products consisted of butanol -ethanol -0 .01 M di- 
sodium tetraborate (20:10:7). The distribution of the 
radioactivity was determined by a scanning apparatus 
(Berthold, Wildbad). Under these conditions two radio- 
activity peaks were found, one (fig. 2, I) with the 
same mobil ity as TSG, and another peak (II) with a 
higher mobility. The unknown, labelled substance 
corresponding to peak II was ehaated from an appro- 
priately excised portion of the thin-layer material with 
chloroform-methanol  (2: i)  and subjected to further 
thin-layer chromatography. This substance migrated 
in three different solvent systemst with the same 
mobility as the ganglioside C_,M3tt (NeuNAc-2,3-Gal- 
1,4-Glc-1,1-(2-N-acyl) sphingosine) which was a 
generous gift from Dr. Wiegandt. 
It seems likely then that by. the action of N-acetyl- 
~3-D-hexosaminidase A, labelled TSG (gangliodise GM2 ) 
was transformed into labelled ganglioside C,M3. Under 
the conditions used 0.1 nmole TSG/min/mg protein are 
1" Besides the system mentioned, the following systems were 
used: (1) Kieselgel G with propanol-water (7 :3); (2) Kiesel- 
gel G with chloroform-methanol-water (120:80:13). 
11 The ganglioside nomenclature of Svennerholm [ 12] is used. 
hydrolyzed. A significant hydrolysis was found be- 
tween pH 4.2 and 5.0, the optimum was about 4.8. 
The reaction could not be observed in a control ex- 
periment in which the enzyme was first heat denatured 
(100°/10 min) and then incubated with the substrate 
(fig. 2). 
It is possible that a slow conversion of the enzyme 
A to an enzyme form with the electrophoretic be- 
haviour of  the enzyme B as described by Robinson and 
Stirling [ 1 ] and as confirmed by us for the purified 
enzyme is also an active process during the 24 hr test 
incubation at 37 ° . It remains, therefore, questionable 
whether the enzyme A in its original or in its changed, 
enzyme B like form is responsible for the degradation 
of TSG. With tile enzyme B itself as prepared accord- 
ing to fig. 1 we observed no significant degradation of 
TSG. It seems likely then that tile enzyme A, un- 
changed or changed, must be responsible for tile de- 
gradation of TSG. 
From these in vitro experiments it seems reason- 
able that N-acetyl-/3-D-hexosaminidase A could also 
catabolize TSG in vivo. The defect of this enzyme 
could then be the main cause for the accumulation of 
TSG in the neural tissue of the Tay-Sachs patients. 
The additional defect of the enzyme B in another 
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Fig. 2. Scan of a thin-layer radiochromatogram showing the result of the action of N-acetyl-~3-D-hexosaminidase A on tritium-label- 
led Tay-Sachs ganglioside (= ganglioside GM2). Experimental conditions ee text. - - ,  active enzyme preparation; ....... , heat dena- 
tured enzyme preparation. Peak 1 = Tay-Sachs ganglioside (ganglioside GM2); peak II = degradation product with the mobility of 
ganglioside GM3. 
variant of  Tay-Sachs disease with visceral involvement 
[3.] could explain the concomitant  accumulat ion of  
tr ihexosylceramide and of kidney globoside which both 
are substrates of  the enzymes A and B. 
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